x
05/2019 Ventures

News iThera

Our portfolio company iThera Medical received the CE Mark for its MSOT Acuity imaging system. This non-invasive, novel technology enables soft tissue imaging without the use of radiation or contrast agents. It combines laser excitation and ultrasound detection for the analysis of hemoglobin, lipids, collagen and other chromophores in tissue. Congratulations!

More

05/2019 Ventures

News Numbrs

Numbrs and Allianz have entered into a cooperation whereby the comprehensive product range of Allianz can be offered directly and on mobile devices in the Numbrs Money Store in the future.

More 

05/2019 Ventures

Occident featured in the VC Magazin

Many thanks to the German VentureCapital Magazin for the presentation of Occident in the current issue. We are delighted to have been able to contribute our experience to the cover story (starting on page 18) and to share our fascination for ventures.

Issue 05/2019 as PDF

04/2019 Ventures

News Resistell

Resistell has attracted CNN Money’s attention with its innovative approach to fighting antibiotic resistance. In her 90-second interview, founder Danuta Cichocka provides exciting insights into her company.

Video to LinkedIn

04/2019 Ventures

News adivo

adivo signs first major collaboration agreement with Bayer Animal Health to jointly develop species-specific therapeutic monoclonal antibodies to address the demand for innovative pet therapies. We congratulate adivo on this major step and look forward to further successful collaborations.

More

03/2019 Ventures

News Implandata

Congratulations to our portfolio company Implandata Ophthalmic Products on the CE certification of the EYEMATE-IO 1.1 microsensor implant for continuous monitoring of intraocular pressure in glaucoma patients! Market entry can thus take place in April 2019.

More

03/2019 Ventures

News Resistell

According to the Swiss business magazine Bilan, our portfolio company Resistell is one of the 50 start-ups in which to invest in 2019. We agree and congratulate Resistell!

More about Resistell

03/2019 Team

New Investment Analyst

Occident welcomes Dr. Kathrin Chojnowska to the team. Following her PhD in neurobiology, Kathrin joins the life sciences team as an Investment Analyst and supports Cédric Barra with her extensive expertise.

Show more